contralateral breast cancer

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
PURPOSE To determine whether adjuvant tamoxifen treatment for breast cancer (BC) is associated with reduced contralateral breast… (More)
  • table 1
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.
PURPOSE Contralateral breast cancer (CBC) is the most frequent new malignancy among women diagnosed with a first breast cancer… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
PURPOSE To determine whether increasing rates of contralateral prophylactic mastectomy (CPM) are due to recognition of risk… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2009
Review
2009
Genetics and Personal Genomics for Personalized Breast Cancer Surgery: Progress and Challenges in Research and Clinical Practice
The age of personal genomics is here. A flood of translational research discoveries may influence also surgeon oncologist. Breast… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
BACKGROUND Little data exist on whether efficacy benefits or side-effects persist after 5 years of adjuvant treatment with an… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Linking contralateral breast cancer with genetics.
Breast cancer is the most common malignancy in females with more than 1,150,000 new cases diagnosed each year worldwide… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer…
PURPOSE Postmastectomy radiotherapy (RT) in high-risk breast cancer patients can reduce locoregional recurrences (LRRs) and… (More)
  • figure 2
  • figure 1
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
PURPOSE To study the potential risk factors, including radiotherapy (RT) for contralateral breast cancer (CBC), in patients… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.
BACKGROUND Risk factors for contralateral breast cancer (CBC) may indicate a benefit for contralateral prophylactic mastectomy… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Contralateral breast cancer: annual incidence and risk parameters.
PURPOSE To screen for factors that might predict the risk of developing metachronous contralateral breast cancer (CBC), taking… (More)
Is this relevant?